Pfizer: Influenza, Human trials
The registry lists 15 Influenza, Human studies with Pfizer as lead sponsor. 1 are open to participants now and 10 have results posted.
Phase 1 5Phase 2 5Phase 3 2Phase 4 1No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Learn About mRNA Vaccines Against Influenza in AdultsRecruitingNCT07431853Phase 2
- A Study About Modified RNA Vaccines Against Influenza in Healthy AdultsCompletedNCT06436703Phase 1/2Results posted
- A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy AdultsCompletedNCT06237049Phase 2Results posted
- A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).CompletedNCT05886777Phase 2Results posted
- This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times.CompletedNCT05858450Results posted
- A Study to Examine Respiratory Combination Vaccines Against Respiratory Syncytial Virus (RSV) and Flu in Older AdultsCompletedNCT05788237Phase 1Results posted
- A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or OlderCompletedNCT05540522Phase 3Results posted
- A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against InfluenzaCompletedNCT05052697Phase 1/2Results posted
- Acute Respiratory Illness Surveillance (AcRIS) With Mobile Application in a Low-Interventional Decentralized Study.CompletedNCT04748445Results posted
- Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults.CompletedNCT02124161Phase 4Results posted
- Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza VaccineCompletedNCT00521586Phase 3Results posted
- A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic InfluenzaCompletedNCT06179446Phase 1
- A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza.WithdrawnNCT06163677
- A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of InfluenzaCompletedNCT05227001Phase 1
- A Study to Look at the Health Outcomes of Patients With COVID-19 and InfluenzaActive, not recruitingNCT05160636